Elotuzumab(HuLuc 63) is a monoclonal antibody that targets the SLAMF7 receptor.Elotuzumab is a compound that directly activates NK cells and induces antibody-dependent cytotoxicity, and can be used in combination with lenalidomide and dexamethasone (Ld) to treat multiple myeloma.
Molecular Weight:
145.4 kDa
Purity:
98.10%
CAS Number:
[915296-00-3]
Target:
Others
T35386
* VAT and and shipping costs not included. Errors and price changes excepted